New Evidence Links APS Antibodies to Severe Mental Illness – Thrombosis Update
Thrombosis Update shared a post on LinkedIn about a paper by Silvia Hoirisch-Clapauch and Antonio E. Nardi:
“New article in Thrombosis Update
Researchers have found that specific antiphospholipid antibody (APLA) profiles dramatically increase the risk of severe mental illness (SMI) in patients with primary APS.
A long-term case-control study suggests that individuals with multiple or high-titer APLA are at a seven to 21-fold increased risk of developing psychosis, severe depression, and/or high impulsivity. The findings support the hypothesis that autoimmunity plays a significant role in severe mental disorders.
This work highlights the need for:
- Routine mental health screening in high-risk APS patients.
- Further research into antibody-reduction protocols as a potential new intervention for treatment-resistant SMI
Lucy Norris TruJournal
Read more here.”
Title: Primary antiphospholipid syndrome and severe mental illness: preliminary results of a long-term case-control study
Authors: Silvia Hoirisch-Clapauch and Antonio E. Nardi

-
Jul 29, 2026, 01:03Seeking a Second Opinion Is Not Being Difficult, It Is a Valid Part of Informed Care – PCOS Awareness Association
-
Jul 29, 2026, 00:57Szabo Gabor: IOTA Day 2026 Advancing Ultrasound in Gynaecological Oncology
-
Jul 29, 2026, 00:55Islam Badr: A Simple Approach to Fetal Heart Screening
-
Jul 29, 2026, 00:50Hardeep Singh: Understanding the Global IVF Travel Landscape
-
Jul 29, 2026, 00:48Asma Khatun: Shaping the Future of Women’s Healthcare at GFWH 2026
-
Jul 29, 2026, 00:43Shaping the Future of Reproductive Medicine at ASRM Innovate – ASRM
-
Jul 29, 2026, 00:37George Condous: Gratitude Makes Every Achievement Greater!
-
Jul 29, 2026, 00:35As AMH Falls, Progesterone May Rise Earlier in Ovarian Stimulation! – Fertility Plus
-
Jul 29, 2026, 00:33An Easy Method for Systematic Fetal Cardiac Screening – ISUOG
